LONG-TERM OUTCOMES FOLLOWING A SWITCH FROM ORIGINATOR ADALIMUMAB TO THE BIOSIMILAR SB5 (IMRALDI) IN IBD
Heather Dolby 1
Laura Lucaciu 1
Caitlin Rees 1
Mathew Lyons 1
Lauranne Derikx 1
Nikolas Plevris 1
Shanna Su 2
Claire O'Hare
Laura Kirkpatrick
Lynne Merchant
Ian D Arnott
Nathan Constantine-Cook
Spyridon (Spyros) Siakavellas
Colin Noble
Philip Jenkinson
Gareth R Jones
Charlie Lees
1 Western General Hospital,Edinburgh,United Kingdom
2 Western General Hospital,Edin
Session
IBD (Posters)
Conference
UEG Week Virtual 2021
Citation
United European Gastroenterology Journal 2021; 9 (Supplement 1)
Login to access library content
Do you need help setting up your myUEG account?
Contact us at [email protected]